Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications

PS Zangabad, S Mirkiani, S Shahsavari… - Nanotechnology …, 2018 - degruyter.com
Liposomes are known to be promising nanoparticles (NPs) for drug delivery applications.
Among the different types of self-assembled NPs, liposomes stand out for their non-toxic …

Liposomes as 'smart'pharmaceutical nanocarriers

RR Sawant, VP Torchilin - Soft Matter, 2010 - pubs.rsc.org
Since the discovery of liposomes, these phospholipid 'bubbles' have received enormous
attention to be recognized as 'smart'pharmaceutical nanocarriers. Recently, much effort has …

Stimulus-responsive liposomes for biomedical applications

AI Antoniou, S Giofrè, P Seneci, D Passarella… - Drug discovery today, 2021 - Elsevier
Liposomes are amphipathic lipidic supramolecular aggregates that are able to encapsulate
and carry molecules of both hydrophilic and hydrophobic nature. They have been widely …

Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery

JO Eloy, MC de Souza, R Petrilli, JPA Barcellos… - Colloids and surfaces B …, 2014 - Elsevier
Although hydrophilic small molecule drugs are widely used in the clinic, their rapid
clearance, suboptimal biodistribution, low intracellular absorption and toxicity can limit their …

Stimuli-responsive smart liposomes in cancer targeting

A Jain, SK Jain - Current drug targets, 2018 - ingentaconnect.com
Background: Liposomes are vesicular carriers which possess aqueous core entrapped
within the lipid bilayer. These are carriers of choice because of biocompatible and …

Updates on responsive drug delivery based on liposome vehicles for cancer treatment

MP Nikolova, EM Kumar, MS Chavali - Pharmaceutics, 2022 - mdpi.com
Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

Liposomes in drug delivery: a patent review (2007–present)

JL Arias - Expert opinion on therapeutic patents, 2013 - Taylor & Francis
Introduction: Drug therapy is frequently limited by the widespread biodistribution of the active
agents and the little specificity for non-healthy cells. Therefore, inadequate drug …

Design of liposomal formulations for cell targeting

E Nogueira, AC Gomes, A Preto… - Colloids and surfaces B …, 2015 - Elsevier
Liposomes have gained extensive attention as carriers for a wide range of drugs due to
being both nontoxic and biodegradable as they are composed of substances naturally …

Optimizing druggability through liposomal formulations: new approaches to an old concept

D Bitounis, R Fanciullino, A Iliadis… - International Scholarly …, 2012 - Wiley Online Library
Developing innovative delivery strategies remains an ongoing task to improve both efficacy
and safety of drug‐based therapy. Nanomedicine is now a promising field of investigation …

Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation

F Bayat, R Hosseinpour-Moghadam, F Mehryab… - Advances in colloid and …, 2020 - Elsevier
Liposomes, lipid-based vesicular systems, have attracted major interest as a means to
improve drug delivery to various organs and tissues in the human body. Recent literature …